glutathione treatment for parkinson& 39 Glutathione—a review on its role and significance in Parkinson's disease - Martin - 2009 - The FASEB Journal Depletion of dopamine in Parkinson's

Godin R, Daussin F, Matecki S, Li T, Petrof BJ, Burelle Y

9) 5 bed volumes of 100 mM NiSO 4

The specific activity of pFeSAN (593 U mg 1 ) was 3.5 times that of FeSAN nanozyme (169 U mg 1 ) and 8471 times that of Fe 3 O 4 (0.07 U mg 1 ) (Fig

doi: 10.2337/db17-0323 54

[DOI] [PubMed] [Google Scholar] 91.Wang CH, Liu C, Cong EZ, et al

It now seems that, in Arabidopsis, DHARs are not normally required for ascorbate recycling or to maintain ascorbate redox state even under conditions that are known to stimulate glutathione oxidation without affecting ascorbate levels (Rahantaniaina et al., 2017), contrary to previously reported findings in tobacco (Chen and Gallie, 2006